Verdence Capital Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.64M Sell
12,508
-133
-1% -$28.6K 0.15% 137
2025
Q4
$2.6M Sell
12,641
-2,329
-16% -$438K 0.15% 143
2025
Q3
$2.45M Sell
14,970
-110
-0.7% -$17K 0.14% 153
2025
Q2
$2.53M Sell
15,080
-4,363
-22% -$648K 0.17% 126
2025
Q1
$2.68M Sell
19,443
-3,476
-15% -$443K 0.2% 116
2024
Q4
$2.71M Sell
22,919
-5,481
-19% -$640K 0.22% 119
2024
Q3
$3.14M Sell
28,400
-3,228
-10% -$338K 0.25% 106
2024
Q2
$3.11M Buy
31,628
+873
+3% +$89K 0.28% 91
2024
Q1
$3.44M Buy
30,755
+692
+2% +$74.7K 0.31% 81
2023
Q4
$3.03M Sell
30,063
-2,881
-9% -$286K 0.29% 92
2023
Q3
$2.86M Buy
32,944
+2,246
+7% +$203K 0.31% 86
2023
Q2
$2.9M Buy
30,698
+548
+2% +$46.3K 0.34% 80
2023
Q1
$2.28M Buy
30,150
+302
+1% +$22.8K 0.28% 95
2022
Q4
$2.29M Sell
29,848
-2,060
-6% -$157K 0.28% 89
2022
Q3
$2.13M Sell
31,908
-4,914
-13% -$311K 0.29% 95
2022
Q2
$1.93M Sell
36,822
-1,604
-4% -$91.2K 0.25% 106
2022
Q1
$2.18M Buy
38,426
+10,160
+36% +$544K 0.25% 104
2021
Q4
$1.46M Buy
28,266
+3,056
+12% +$150K 0.17% 133
2021
Q3
$1.25M Buy
25,210
+38
+0.2% +$2.06K 0.16% 141
2021
Q2
$1.44M Buy
25,172
+1,708
+7% +$99.8K 0.2% 117
2021
Q1
$1.43M Buy
23,464
+3,670
+19% +$203K 0.24% 109
2020
Q4
$1.06M Buy
19,794
+668
+3% +$34.7K 0.2% 123
2020
Q3
$898K Buy
19,126
+3,603
+23% +$185K 0.21% 123
2020
Q2
$810K Sell
15,523
-10,404
-40% -$536K 0.2% 128
2020
Q1
$1.24M Sell
25,927
-2,880
-10% -$150K 0.37% 77
2019
Q4
$1.46M Sell
28,807
-45
-0.2% -$2.32K 0.36% 75
2019
Q3
$1.36M Buy
28,852
+5,973
+26% +$273K 0.38% 74
2019
Q2
$1.08M Buy
22,879
+9,013
+65% +$416K 0.31% 94
2019
Q1
$668K Buy
+13,866
New +$695K 0.18% 136
2018
Q2
Sell
-3,382
Closed -$212K 296
2018
Q1
$212K Buy
+3,382
New +$232K 0.05% 266

Other funds holding CAH

Verdence Capital Advisors's CAH Position: Q1 2026 in Review

Verdence Capital Advisors reduced its Cardinal Health (CAH) stake by 1.1% in Q1 2026, selling an estimated $28.6K and leaving 12,508 shares worth $2.64M. The position accounts for 0.15% of the portfolio, ranked #137.

Verdence Capital Advisors first reported a position in CAH in Q1 2018 and has held it in 30 quarters since. The position peaked at $3.44M in Q1 2024. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Verdence Capital Advisors held 12,508 shares of Cardinal Health worth $2.64M as of Q1 2026.
  • Verdence Capital Advisors sold 133 Cardinal Health shares in Q1 2026, an estimated $28.6K.
  • Cardinal Health made up 0.15% of Verdence Capital Advisors's portfolio in Q1 2026, its #137 holding.
  • Verdence Capital Advisors first reported a position in Cardinal Health in Q1 2018 and has held it in 30 quarters since.
  • Verdence Capital Advisors's Cardinal Health position peaked at $3.44M in Q1 2024.
  • 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Verdence Capital Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.